A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infants

Pediatric Research

Volumn 65, Issue 5, 2009, Pages 574-579

  Löfqvist, Chatarina ^a   Niklasson, Aimon ^a   Engström, Eva ^a   Friberg, Lena E ^b   Camacho Hübner, Cecilia ^c   Ley, David ^d   Borg, Jan ^e   Smith, Lois E H ^f   Hellström, Ann ^a,g  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d LUND UNIVERSITY   (Sweden)

^e Uppsala Science Park   (Sweden)

^f HARVARD MEDICAL SCHOOL   (United States)

^g QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; MECASERMIN RINFABATE; POTASSIUM; SODIUM; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG HALF LIFE; DRUG INFUSION; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MALE; MAXIMUM PLASMA CONCENTRATION; NEWBORN; POTASSIUM BLOOD LEVEL; PREMATURITY; PRIORITY JOURNAL; SODIUM BLOOD LEVEL;

BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; HALF-LIFE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFUSIONS, INTRAVENOUS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; RECOMBINANT PROTEINS;

EID: 69049098085     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e31819d9e8c     Document Type: Article

References (34)

1. Gluckman PD 1995 Clinical review 68: the endocrine regulation of fetal growth in late gestation: the role of insulin-like growth factors. J Clin Endocrinol Metab 80:1047-1050
2. Hellstrom A, Perruzzi C, Ju M, Engstrom E, Hard AL, Liu JL, Albertsson-Wikland K, Carlsson B, Niklasson A, Sjodell L, LeRoith D, Senger DR, Smith LE 2001 Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A 98:5804-5808
3. Russo VC, Gluckman PD, Feldman EL, Werther GA 2005 The insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev 26:916-943
4. Ye P, D'Ercole AJ 2006 Insulin-like growth factor actions during development of neural stem cells and progenitors in the central nervous system. J Neurosci Res 83:1-6
5. Hellstrom A, Engstrom E, Hard AL, Albertsson-Wikland K, Carlsson B, Niklasson A, Lofqvist C, Svensson E, Holm S, Ewald U, Holmstrom G, Smith LE 2003 Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 112:1016-1020
6. Holly J, Perks C 2006 The role of insulin-like growth factor binding proteins. Neuroendocrinology 83:154-160
7. Lofqvist C, Chen J, Connor KM, Smith AC, Aderman CM, Liu N, Pintar JE, Ludwig T, Hellstrom A, Smith LE 2007 IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. Proc Natl Acad Sci U S A 104:10589-10594
8. Hansen-Pupp I, Hellstrom-Westas L, Cilio CM, Andersson S, Fellman V, Ley D 2007 Inflammation at birth and the insulin-like growth factor system in very preterm infants. Acta Paediatr 96:830-836
9. Ashton IK, Zapf J, Einschenk I, MacKenzie IZ 1985 Insulin-like growth factors (IGF) 1 and 2 in human foetal plasma and relationship to gestational age and foetal size during midpregnancy. Acta Endocrinol (Copenh) 110:558-563
10. Lassarre C, Hardouin S, Daffos F, Forestier F, Frankenne F, Binoux M 1991 Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res 29:219-225
11. Engstrom E, Niklasson A, Wikland KA, Ewald U, Hellstrom A 2005 The role of maternal factors, postnatal nutrition, weight gain, and gender in regulation of serum IGF-I among preterm infants. Pediatr Res 57:605-610
12. Lofqvist C, Engstrom E, Sigurdsson J, Hard AL, Niklasson A, Ewald U, Holmstrom G, Smith LE, Hellstrom A 2006 Postnatal head growth deficit among premature infants parallels retinopathy of prematurity and insulin-like growth factor-1 deficit. Pediatrics 117:1930-1938
13. Langford K, Nicolaides K, Miell JP 1998 Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy. Hum Reprod 13:1389-1393
14. Camacho-Hubner C, Rose S, Preece MA, Sleevi M, Storr HL, Miraki-Moud F, Minuto F, Frystyk J, Rogol A, Allan G, Sommer A, Savage MO 2006 Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGFbinding protein-3 complex administered to patients with growth harmone insensitivity syndrome. J Clin Endocrinol Metab 91:1246-1253
15. Hansen-Pupp I, Engstrom E, Niklasson A, Berg AC, Fellman V, Lofqvist C, Hellstrom A, Ley D 2008 Fresh-frozen plasma as a source of exogenous insulin-like growth factor I in the extremely preterm infant. J Clin Endocrinol Metab 94:477-482
16. Blum WF, Breier BH 1994 Radioimmunoassays for IGFs and IGFBPs. Growth Regul 4:11-19
17. Beal SL, Sheiner LB, Boeckmann AJ (eds) 1989-2006 NONMEM Users Guides. GloboMax, Inc., Ellicott City, MD
18. Anderson BJ, Holford NH 2008 Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol 48:303-332
19. Beardsall K, Ogilvy-Stuart AL, Frystyk J, Chen JW, Thompson M, Ahluwalia J, Ong KK, Dunger DB 2007 Early elective insulin therapy can reduce hyperglycemia and increase insulin-like growth factor-I levels in very low birth weight infants. J Pediatr 151:611-617; 617.e611
20. Clemmons DR, Moses AC, McKay MJ, Sommer A, Rosen DM, Ruckle J 2000 The combination of insulin-like growth factor I and insulin-like growth factorbinding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity. J Clin Endocrinol Metab 85:1518-1524
21. Saukkonen T, Shojaee-Moradie F, Williams RM, Amin R, Yuen KC, Watts A, Acerini CL, Umpleby AM, Dunger DB 2006 Effects of recombinant human IGF-I/ IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes. Diabetes 55:2365-2370
22. Herndon DN, Ramzy PI, DebRoy MA, Zheng M, Ferrando AA, Chinkes DL, Barret JP, Wolfe RR, Wolf SE 1999 Muscle protein catabolism after severe burn: effects of IGF-1/IGFBP-3 treatment. Ann Surg 229:713-720; discussion 720 -722
23. Spies M, Wolf SE, Barrow RE, Jeschke MG, Herndon DN 2002 Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children. Crit Care Med 30:83-88
24. Cohen P 2006 Overview of the IGF-I system. Horm Res 65:3-8
25. Hikino S, Ihara K, Yamamoto J, Takahata Y, Nakayama H, Kinukawa N, Narazaki Y, Hara T 2001 Physical growth and retinopathy in preterm infants: involvement of IGF-I and GH. Pediatr Res 50:732-736
26. Ranke MB 1996 Treatment of growth hormone insensitivity syndrome (GHIS) with insulin-like growth factor (IGF-I). Baillieres Clin Endocrinol Metab 10:401- 410
27. Williams RM, McDonald A, O'Savage M, Dunger DB 2008 Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX. Expert Opin Drug Metab Toxicol 4:311-324
28. Frystyk J, Hussain M, Skjaerbaek C, Porksen N, Froesch ER, Orskov H 1999 The pharmacokinetics of free insulin-like growth factor-I in healthy subjects. Growth Horm IGF Res 9:150-156
29. Mizuno N, Kato Y, Iwamoto M, Urae A, Amamoto T, Niwa T, Sugiyama Y 2001 Kinetic analysis of the disposition of insulin-like growth factor 1 in healthy volunteers. Pharm Res 18:1203-1209
30. Kajantie E 2003 Insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, phosphoisoforms of IGFBP-1 and postnatal growth in very-low-birth-weight infants. Horm Res 60:124-130
31. Lofqvist C, Andersson E, Sigurdsson J, Engstrom E, Hard AL, Niklasson A, Smith LE, Hellstrom A 2006 Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity. Arch Ophthalmol 124:1711-1718
32. Smith LE, Kopchick JJ, Chen W, Knapp J, Kinose F, Daley D, Foley E, Smith RG, Schaeffer JM 1997 Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 276:1706-1709
33. Smith LE, Shen W, Perruzzi C, Soker S, Kinose F, Xu X, Robinson G, Driver S, Bischoff J, Zhang B, Schaeffer JM, Senger DR 1999 Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 5:1390-1395
34. Villegas Becerril E, Gonzalez Fernandez R, Fernandez Molina F, Gallardo Galera JM 2005 Growth factor levels and ROP. Ophthalmology 112:2238